Mäding P - Search Results

1

Synthesis of [¹⁸F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective.

Kniess T, Zessin J, Mäding P, Kuchar M, Kiss O, Kopka K. Kniess T, et al. Among authors: mading p. EJNMMI Radiopharm Chem. 2023 Mar 10;8(1):5. doi: 10.1186/s41181-023-00190-7. EJNMMI Radiopharm Chem. 2023. PMID: 36897480 Free PMC article.

2

Factors affecting the specific activity of [18F]fluoride from a [18O]water target.

Füchtner F, Preusche S, Mäding P, Zessin J, Steinbach J. Füchtner F, et al. Among authors: mading p. Nuklearmedizin. 2008;47(3):116-9. Nuklearmedizin. 2008. PMID: 18493691

3

Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.

Füchtner F, Zessin J, Mäding P, Wüst F. Füchtner F, et al. Among authors: mading p. Nuklearmedizin. 2008;47(1):62-4. Nuklearmedizin. 2008. PMID: 18278215

4

Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.

Hesse S, Brust P, Mäding P, Becker GA, Patt M, Seese A, Sorger D, Zessin J, Meyer PM, Lobsien D, Laudi S, Habermann B, Füchtner F, Luthardt J, Bresch A, Steinbach J, Sabri O. Hesse S, et al. Among authors: mading p. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1001-11. doi: 10.1007/s00259-012-2078-z. Epub 2012 Feb 17. Eur J Nucl Med Mol Imaging. 2012. PMID: 22349718 Clinical Trial.

5

18F-labelled CCR1-receptor antagonist is not suitable for imaging of Alzheimer's disease.

Beuthien-Baumann B, Holthoff VA, Mäding P, Bergmann R, Pawelke B, Holl G, von Kummer R, Kotzerke J, van den Hoff J. Beuthien-Baumann B, et al. Among authors: mading p. Nuklearmedizin. 2012;51(6):239-43. doi: 10.3413/Nukmed-0457-12-01. Epub 2012 Jun 11. Nuklearmedizin. 2012. PMID: 22684530 Clinical Trial.

6

Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: comparison of different tumor cells and primary endothelial cells.

Oswald J, Treite F, Haase C, Kampfrath T, Mäding P, Schwenzer B, Bergmann R, Pietzsch J. Oswald J, et al. Among authors: mading p. Cancer Lett. 2007 Aug 28;254(1):102-10. doi: 10.1016/j.canlet.2007.02.016. Epub 2007 Apr 2. Cancer Lett. 2007. PMID: 17400370

7

Module-assisted preparation of 64Cu with high specific activity.

Thieme S, Walther M, Pietzsch HJ, Henniger J, Preusche S, Mäding P, Steinbach J. Thieme S, et al. Among authors: mading p. Appl Radiat Isot. 2012 Apr;70(4):602-8. doi: 10.1016/j.apradiso.2012.01.019. Epub 2012 Feb 1. Appl Radiat Isot. 2012. PMID: 22326369

8

Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N epsilon-carboxymethyllysine (CML) and N epsilon-carboxyethyllysine (CEL).

Bergmann R, Helling R, Heichert C, Scheunemann M, Mäding P, Wittrisch H, Johannsen B, Henle T. Bergmann R, et al. Among authors: mading p. Nahrung. 2001 Jun;45(3):182-8. doi: 10.1002/1521-3803(20010601)45:3<182::AID-FOOD182>3.0.CO;2-Q. Nahrung. 2001. PMID: 11455785

9

Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[(18)F]fluorobenzoate ([(18)F]SFB).

Mäding P, Füchtner F, Wüst F. Mäding P, et al. Appl Radiat Isot. 2005 Sep;63(3):329-32. doi: 10.1016/j.apradiso.2005.03.005. Appl Radiat Isot. 2005. PMID: 15949940

10

Simultaneous study of the biodistribution of radio-yttrium complexed with EDTMP and citrate ligands in tumour-bearing rats.

Beyer GJ, Bergmann R, Kampf G, Mäding P, Rösch F. Beyer GJ, et al. Among authors: mading p. Int J Rad Appl Instrum B. 1992 Feb;19(2):201-3. doi: 10.1016/0883-2897(92)90008-m. Int J Rad Appl Instrum B. 1992. PMID: 1601673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page